Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,922
Closed -$281K 390
2025
Q3
$281K Sell
1,922
-275
-13% -$41.6K ﹤0.01% 341
2025
Q2
$343K Buy
+2,197
New +$348K ﹤0.01% 309
2024
Q1
Sell
-1,248
Closed -$246K 387
2023
Q4
$246K Sell
1,248
-9
-0.7% -$1.59K ﹤0.01% 346
2023
Q3
$219K Buy
1,257
+31
+3% +$5.63K ﹤0.01% 357
2023
Q2
$211K Buy
+1,226
New +$212K ﹤0.01% 363
2022
Q3
Sell
-1,363
Closed -$235K 385
2022
Q2
$235K Buy
1,363
+15
+1% +$2.59K ﹤0.01% 356
2022
Q1
$254K Buy
1,348
+248
+23% +$49K ﹤0.01% 352
2021
Q4
$268K Buy
1,100
+6
+0.5% +$1.31K ﹤0.01% 352
2021
Q3
$212K Buy
+1,094
New +$221K ﹤0.01% 379

Other funds holding ZTS

Welch & Forbes's ZTS Position: Q4 2025 in Review

Welch & Forbes sold out of Zoetis (ZTS) in Q4 2025, closing a stake of 1,922 shares — an estimated $281K sold.

Welch & Forbes first reported a position in ZTS in Q3 2021 and held it in 9 quarters. The position peaked at $343K in Q2 2025. 1,682 funds tracked by Wall St. Rank hold ZTS as of Q4 2025.

  • Welch & Forbes reported no remaining Zoetis position as of Q4 2025 after selling out during the quarter.
  • Welch & Forbes sold 1,922 Zoetis shares in Q4 2025, an estimated $281K.
  • Welch & Forbes first reported a position in Zoetis in Q3 2021 and held it in 9 quarters.
  • Welch & Forbes's Zoetis position peaked at $343K in Q2 2025.
  • 1,682 funds tracked by Wall St. Rank held Zoetis as of Q4 2025.

Based on Welch & Forbes's 13F filing for Q4 2025, filed 10 Feb 2026.